Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects
Clinical trial NCT02956499 · COMPLETED
Trial details
- NCT number
- NCT02956499
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-24
- Primary completion
- 2017-07-03
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.